Clinical trial
S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo…
NCT00110734 · ZARS Pharma Inc., Industry · Completed
Key facts
| NCT number | NCT00110734 |
|---|---|
| Title | S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults |
| Official title | A Randomized, Double-Blind, Placebo Controlled, Paired Study Evaluating S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) for Induction of Local Dermal Anesthesia for Laser-Assisted Tattoo Removal in Adults |
| Lead sponsor | ZARS Pharma Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%) |
| Enrollment | 60 |
| Completion | Sep 1, 2005 |
| First posted | May 13, 2005 |
| Last update posted | Sep 23, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: